Dr. Douglas Robert Dolnak, DO

Dr. Dolnak practices at Pacific Health Systems in National City, California.

Dr. Dolnak's NPI, 1316147085, was assigned on July 20, 2007. Dr. Dolnak graduated from Kansas City University of Medicine and Biosciences College of Osteopathic Medicine in 1990. Dr. Dolnak holds California license 20A6059.

Dr. Dolnak's primary practice is Pacific Health Systems, at 610 Euclid Ave, National City, CA 91950 in San Diego County. The practice phone is (619) 267-9257.

Dr. Dolnak's primary practice is Pacific Health Systems in National City, California. The medical group on file is Pacific Health Systems. Dmand AI also links Dr. Dolnak to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dolnak practices, 3 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Dolnak's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Dolnak is board certified in psychiatry by the AOA Board of Neurology and Psychiatry. Dmand AI has Dr. Dolnak's licenses on file in 2 states: California and Illinois.

Dmand AI lists anxiety, bipolar disorder, depression, intellectual and developmental disabilities and schizophrenia among the conditions Dr. Dolnak treats.

CMS data shows 197 Medicare services from Dr. Dolnak across 3 procedure codes in 2024, for 62 Medicare patients. Medicare paid $14,380 for them.

CMS counts 62 Medicare patients who saw Dr. Dolnak in 2024. The largest group is 65 to 74, with 28 patients. 75% of them have high blood pressure, and 74% have high cholesterol. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dolnak's median patient age at 56, with 51% women.

In 2024, Dr. Dolnak wrote 1,561 Medicare Part D claims for 67 patients. 92% of them were for generic drugs. CMS names the drug for 1,474 of them, across 35 drugs with 11 or more claims each, at $228,607 in total drug cost. In 2023, CMS named 1,443 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 59 out of 100 for Dr. Dolnak for performance year 2024, reported as part of a group. Dr. Dolnak accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Dolnak.

Dmand AI links Dr. Dolnak to 2 clinical trials. Conditions studied include Depressive Disorder, Major, Schizophrenia and Depressive Disorder. Open Payments lists research payments to Dr. Dolnak that name 1 trial.

CMS Open Payments shows 638 general payments to Dr. Dolnak from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Alkermes, Inc. paid the most, $2,390. It also lists 30 research payments totaling $5,705 from 2016 to 2019, naming 1 clinical trial.

Dr. Dolnak graduated from Kansas City University of Medicine and Biosciences College of Osteopathic Medicine in 1990. Dr. Dolnak is a member of AOA.

Dr. Dolnak is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.